Estrogen receptor-positive breast cancer
Conditions
Interventions
Liang-xue-shu-gan-fang group:Liang-xue-shu-gan-fang
Comparison group:Tamoxifen
Liang-xue-shu-gan-fang group:Tamoxifen
Sponsors
Shanghai Chinese Medicine Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. By pathology or cytology and immunohistochemistry diagnosed estrogen receptor-positive breast cancer patients; 2. Between the ages of 18 to 75 years (including 18 and 75 years); 3. Expected lifetime of more than 6 months; 4. KPS score>=60; 5. No radiotherapy and chemotherapy, Chinese medicine treatment and within one month.
Exclusion criteria
Exclusion criteria: 1. Combined with other functions such as heart, kidney dysfunction, respiratory dysfunction and other major diseases; 2. Combined with other factors of endocrine diseases; 3. Pregnancy or breast-feeding women; 4. Cognitive decline and other factors and not by the normal exchange; 5. Not accept tamoxifen citrate endocrine treatment; 6. The researchers unwilling to cooperate; 7. History of allergy or failing to medication or incomplete information; 8. Those who do not meet the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| progression-free survival;tumor marker;Immunity;traditional Chinese medicine symptom; | — |
Countries
China
Contacts
Public ContactZhu Wei Kang
Shanghai Chinese Medicine Hospital
Outcome results
None listed